Brief: XOMA Receives $8.1 Mln Milestone Related To Day One Biopharmaceuticals' Sale Of Its Priority Review Voucher
June 12 (Reuters) - XOMA Corp XOMA.O :
* XOMA RECEIVES $8.1 MILLION MILESTONE RELATED TO DAY ONE
BIOPHARMACEUTICALS’ SALE OF ITS PRIORITY REVIEW VOUCHER
Source text for Eikon: ID:nGNX5bN9y8
Further company coverage: XOMA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xoma Royalty
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM